Abstract
In this study, liquid crystalline nanoparticles (LCN) have been proposed as new carrier for topical delivery of finasteride (FNS) in the treatment of androgenetic alopecia. To evaluate the potential of this nanocarrier, FNS-loaded LCN was prepared by ultrasonication method and characterized for size, shape, in vitro release, and skin permeation–retention properties. The particle size ranged from 153.8 to 170.2 nm with a cubical shape and exhibited controlled release profile with less than 20% of the drug released in the first 24 h. The release profile was significantly altered with addition of different additives. Formulation with lower monoolein exhibited higher skin permeation with a flux rate of 0.061 ± 0.005 μg cm−2 h−1 in 24 h. The permeation however, significantly increased with glycerol, propylene glycol, and polyethylene glycol 400, while it declined for the addition of oleic acid. A similar trend was observed with skin retention study. In conclusion, FNS-loaded LCN could be advocated as a viable alternative for oral administration of the drug.
Similar content being viewed by others
REFERENCES
Bingham KD, Shaw DA. The metabolism of testosterone by human male scalp skin. J Endocrinol. 1973;57:111–21.
Schweikert HU, Wilson JD. Regulation of human hair growth by steroid hormones. I. Testosterone metabolism in isolated hairs. J Clin Endocrinol Metab. 1974;38:811–9.
Rathnayake D, Sinclair R. Male androgenetic alopecia. Expert Opin Pharmacother. 2010;11:1295–304.
Finn DA, Beadles-Bohling AS, Beckley EH, Ford MM, Gililland KR, Gorin-Meyer RE, Wiren KM. A new look at the 5α-reductase inhibitor finasteride. CNS Drug Rev. 2006;12:53–76.
Irwig MS, Kolukula S. Persistent sexual side effects of finasteride for male pattern hair loss. J Sex Med. 2011;8:1747–53.
Chaudhary UB, Turner JS. Finasteride. Expert Opin Drug Metab Toxicol. 2010;6:873–81.
Kogan A, Garti N. Microemulsions as transdermal drug delivery vehicles. Adv Colloid Interface Sci. 2006;123–126:369–85.
Padois K, Cantiéni C, Bertholle V, Bardel C, Pirot F, Falson F. Solid lipid nanoparticles suspension versus commercial solutions for dermal delivery of minoxidil. Int J Pharm. 2011;416:300–4.
Carr MG, Corish J, Corrigan OI. Drug delivery from a liquid crystalline base across Visking and human stratum corneum. Int J Pharm. 1997;157:35–42.
Helledi LS, Schubert L. Release kinetics of acyclovir from a suspension of acyclovir incorporated in a cubic phase delivery system. Drug Dev Ind Pharm. 2001;27:1073–81.
Bender J, Ericson MB, Merclin N, Iani V, Rosén A, Engström S, Moan J. Lipid cubic phases for improved topical drug delivery in photodynamic therapy. J Control Release. 2005;106:350–60.
Popescu G, Baraukas J, Nylander T, Tiberg F. Liquid crystalline phase and their dispersions in aqueous mixtures of glyceryl monooleate and glyceryl monoethyl ether. Langmuir. 2007;23:496–503.
Fraser S, Separovic F, Polyzos A. Cubic phases of ternary amphiphile-water systems. Eur Biophys J. 2009;39:83–90.
Larsson K. Cubic lipid-water phases: structures and biomembrane aspects. J Phys Chem. 1989;93:7304–14.
Esposito E, Cortesi R, Drechsler M, Paccamiccio L, Mariani P, Contado C, Stellin E, Menegatti E, Bonina F, Puglia C. Cubosome dispersions as delivery systems for percutaneous administration of indomethacin. Pharm Res. 2005;22:2163–73.
Turchiello RF, Vena FC, Maillard P, Souza CS, Bentley MV, Tedesco AC. Cubic phase gel as a drug delivery system for topical application of 5-ALA, its ester derivatives and m-THPC in photodynamic therapy (PDT). J Photochem Photobiol B. 2003;70:1–6.
Yariv D, Efrat R, Libster D, Aserin A, Garti N. In vitro permeation of diclofenac salts from lyotropic liquid crystalline systems. Colloids Surf B Biointerfaces. 2010;78:185–92.
Ogiso T, Iwaki M, Paku T. Effect of various enhancers on transdermal penetration of indomethacin and urea and relationship between penetration parameters and enhancement factors. J Pharm Sci. 1995;84:482–8.
Drummond CJ, Fong C. Surfactant self-assembly objects as novel drug delivery vehicles. Curr Opin Colloid Interface Sci. 1999;4:449–56.
Boyd BJ, Whittaker DV, Khoo S, Davey G. Lyotropic liquid crystalline phases formed from glycerate surfactants as sustained release drug delivery systems. Int J Pharm. 2006;309:218–26.
Gan L, Han S, Shen J, Zhu J, Zhu C, Zhang X, Gan Y. Self-assembled liquid crystalline nanoparticles as a novel ophthalmic delivery system for dexamethasone: improving preocular retention and ocular bioavailability. Int J Pharm. 2010;396:179–87.
Sintov A, Serafimovich S, Gilhar A. New topical antiandrogenic formulations can stimulate hair growth in human bald scalp grafted onto mice. Int J Pharm. 2000;194:125–34.
Hajheydari Z, Akbari J, Saeedi M, Shokoohi L. Comparing the therapeutic effects of finasteride gel and tablet in treatment of the androgenetic alopecia. Indian J Dermatol Venereol Leprol. 2009;75:47–51.
Tabbakhian M, Tavakoli N, Jaafari M, Daneshamouz S. Enhancement of follicular delivery of finasteride by liposomes and niosomes 1. In vitro permeation and in vivo deposition studies using hamster flank and ear models. Int J Pharm. 2006;323:1–10.
Lee SI, Nagayya-Sriraman S, Shanmugam S, Baskaran R, Yong CS, Yoon SK, Choi HG, Yoo BK. Effect of charge carrier on skin penetration, retention, and hair growth of topically applied finasteride-containing liposomes. Biomol Ther. 2011;19:231–6.
Dong YD, Larson I, Hanley T, Boyd BJ. Bulk and dispersed aqueous phase behavior of phytantriol: effect of vitamin E acetate and F127 polymer on liquid crystal nanostructure. Langmuir. 2006;22:9512–8.
Price VH. Treatment of hair loss. N Engl J Med. 1999;341:964–73.
Gustafsson J, Ljusberg-Wahren H, Almgren M, Larsson K. Submicron particles of reversed lipid phases in water stabilized by a nonionic amphiphilic polymer. Langmuir. 1997;13:6964–71.
Spicer PT, Hayden KL. Novel process for producing cubic liquid crystalline nanoparticles (cubosomes). Langmuir. 2001;17:5748–56.
Thapa R, Baskaran R, Madheswaran T, Kim JO, Yong CS, Yoo BK. Preparation, characterization, and release study of tacrolimus-loaded liquid crystalline nanoparticles. J Disp Sci Technol. 2011. doi:10.1080/01932691.2011.648462.
Guo C, Wang J, Cao F, Lee RJ, Zhai G. Lyotropic liquid crystal systems in drug delivery. Drug Discov Today. 2010;15:1032–40.
Spicer PT. Progress in liquid crystalline dispersions: cubosomes. Curr Opin Colloid Interface Sci. 2005;10:274–9.
Kwon TK, Kim JC. In vitro skin permeation of monoolein nanoparticles containing hydroxypropyl β-cyclodextrin/minoxidil complex. Int J Pharm. 2010;392:268–73.
Schubert MA, Müller-Goymann CC. Characterization of surface-modified solid lipid nanoparticles (SLN): influence of lecithin and nonionic emulsifier. Eur J Pharm Biopharm. 2005;61:77–86.
Alfons K, Engstrom S. Drug compatability with the sponge phases formed in monoolein, water, and propylene glycol or poly(ethylene glycol). J Pharm Sci. 1998;87:1527–30.
Angelova A, Angelov B, Mutafchieva R, Garamus VM, Lesieur S, Funari SS, Willumeit R, Couvreur P. Swelling of a sponge lipid phase via incorporation of a nonionic amphiphile: SANS and SAXS studies. Prog Colloid Polym Sci. 2011;138:1–6.
Chang CM, Bodmeier R. Effect of dissolution media and additives on the drug release from cubic phase delivery systems. J Control Release. 1997;46:215–22.
Caboi F, Nylander T, Razumas V, Talaikyté Z, Monduzzi M, Larsson K. Structural effects, mobility, and redox behavior of vitamin K1 hosted in the monoolein/water liquid crystalline phases. Langmuir. 1997;13:5476–83.
Lara MG, Bentley MV, Collett JH. In vitro drug release mechanism and drug loading studies of cubic phase gels. Int J Pharm. 2005;293:241–50.
Lopes LB, Lopes JL, Oliveria CR, Thomazini JA, Garcia MT, Fantini MC, Collett JH, Bentley MV. Liquid crystalline phase of monoolein and water for topical delivery of cyclosporin A: characterization and study of in vitro and in vivo delivery. Eur J Pharm Biopharm. 2006;63:146–55.
Lopes LB, Ferreira DA, Paula DD, Garcia MT, Thomazini JA, Fantini MC, Bentley MV. Reverse hexagonal phase nanodispersion of peptide of monoolein and oleic acid for topical delivery of peptides: in vitro and in vivo penetration of cyclosporin A. Pharm Res. 2006;23:1332–42.
Lopes LB, Collett JH, Bentley MV. Topical delivery of cyclosporin A: an in vitro study using monoolein as a penetration enhancer. Eur J Pharm Biopharm. 2005;60:25–30.
Herai H, Gratieri T, Thomazine JA, Bentley MV, Lopez RFV. Doxorubicin skin penetration from monoolein-containing propylene glycol formulations. Int J Pharm. 2007;329:88–93.
Han IH, Choi SU, Nam DY, Park YM, Kang MJ, Kang KH, Kim YM, Bae G, Oh IY, Park JH, Ye JS, Choi YB, Kim DK, Lee J, Choi YW. Identification and assessment of permeability enhancing vehicles for transdermal delivery of glucosamine hydrochloride. Arch Pharm Res. 2010;33:293–9.
ACKNOWLEDGMENTS
This work was funded by BK 21 offered by Korean Government.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Madheswaran, T., Baskaran, R., Thapa, R.K. et al. Design and In Vitro Evaluation of Finasteride-Loaded Liquid Crystalline Nanoparticles for Topical Delivery. AAPS PharmSciTech 14, 45–52 (2013). https://doi.org/10.1208/s12249-012-9888-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1208/s12249-012-9888-y